BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 50 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,196,150 | -91.0% | 3,295,000 | -90.9% | 0.00% | -100.0% |
| Q2 2023 | $35,651,491 | -4.0% | 36,295,000 | +0.3% | 0.00% | 0.0% |
| Q1 2023 | $37,135,346 | -3.7% | 36,195,000 | -0.4% | 0.00% | 0.0% |
| Q4 2022 | $38,567,642 | +161.4% | 36,340,000 | +144.1% | 0.00% | 0.0% |
| Q3 2022 | $14,753,000 | +3.9% | 14,890,000 | +3.8% | 0.00% | – |
| Q2 2022 | $14,202,000 | +9.1% | 14,345,000 | +10.2% | 0.00% | – |
| Q1 2022 | $13,013,000 | +5.3% | 13,020,000 | +10.2% | 0.00% | – |
| Q4 2021 | $12,359,000 | +104.0% | 11,820,000 | +99.7% | 0.00% | – |
| Q3 2021 | $6,057,000 | +5.9% | 5,920,000 | +7.2% | 0.00% | – |
| Q2 2021 | $5,721,000 | +20.4% | 5,520,000 | +17.6% | 0.00% | – |
| Q1 2021 | $4,751,000 | +17.7% | 4,695,000 | +24.9% | 0.00% | – |
| Q4 2020 | $4,035,000 | +55.4% | 3,760,000 | +51.9% | 0.00% | – |
| Q3 2020 | $2,597,000 | -28.6% | 2,475,000 | -16.8% | 0.00% | – |
| Q2 2020 | $3,636,000 | +40.2% | 2,975,000 | +20.2% | 0.00% | – |
| Q1 2020 | $2,594,000 | +139.5% | 2,475,000 | +141.5% | 0.00% | – |
| Q4 2019 | $1,083,000 | +7.4% | 1,025,000 | 0.0% | 0.00% | – |
| Q3 2019 | $1,008,000 | -5.3% | 1,025,000 | 0.0% | 0.00% | – |
| Q2 2019 | $1,064,000 | +1.4% | 1,025,000 | 0.0% | 0.00% | – |
| Q1 2019 | $1,049,000 | -12.1% | 1,025,000 | -14.6% | 0.00% | – |
| Q4 2018 | $1,193,000 | +9.2% | 1,200,000 | +17.1% | 0.00% | – |
| Q3 2018 | $1,092,000 | +54.5% | 1,025,000 | +46.4% | 0.00% | – |
| Q2 2018 | $707,000 | -31.6% | 700,000 | -36.4% | 0.00% | – |
| Q1 2018 | $1,033,000 | -20.2% | 1,100,000 | -15.4% | 0.00% | – |
| Q4 2017 | $1,295,000 | -1.7% | 1,300,000 | 0.0% | 0.00% | – |
| Q3 2017 | $1,317,000 | – | 1,300,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 30,138,000 | $29,510,000 | 3.72% |
| PFM Health Sciences, LP | 45,910,000 | $46,002,000 | 1.72% |
| Cheyne Capital Management (UK) LLP | 2,320,000 | $2,330,000 | 1.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 41,077,000 | $41,277,000 | 0.66% |
| SSI INVESTMENT MANAGEMENT LLC | 9,071,000 | $9,068,000 | 0.50% |
| PALISADE CAPITAL MANAGEMENT, LP | 14,548,000 | $14,612,000 | 0.34% |
| RWC Asset Management LLP | 7,500,000 | $7,552,000 | 0.21% |
| KBC Group NV | 400,000 | $40,316,000 | 0.15% |
| PROSPECTOR PARTNERS LLC | 1,000,000 | $1,000,000 | 0.12% |
| MACKAY SHIELDS LLC | 11,822,000 | $11,816,000 | 0.10% |